Metastatic Prostate Cancer Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mono
1.2.3 Combination
1.2.4 Mono/Combination
1.3 Market by Application
1.3.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2017-2028)
2.2 Metastatic Prostate Cancer Treatment Growth Trends by Region
2.2.1 Metastatic Prostate Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metastatic Prostate Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Metastatic Prostate Cancer Treatment Market Dynamics
2.3.1 Metastatic Prostate Cancer Treatment Industry Trends
2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
2.3.4 Metastatic Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2021
3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Metastatic Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metastatic Prostate Cancer Treatment Market Size (2017-2028)
6.2 North America Metastatic Prostate Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America Metastatic Prostate Cancer Treatment Market Share by Type (2017-2028)
6.3 North America Metastatic Prostate Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America Metastatic Prostate Cancer Treatment Market Share by Application (2017-2028)
6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2017-2028)
7.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe Metastatic Prostate Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe Metastatic Prostate Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2017-2028)
9.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Metastatic Prostate Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Metastatic Prostate Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Details
11.1.2 AB Science Business Overview
11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.1.5 AB Science Recent Developments
11.2 BeiGene
11.2.1 BeiGene Company Details
11.2.2 BeiGene Business Overview
11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.2.5 BeiGene Recent Developments
11.3 eFFECTOR Therapeutics
11.3.1 eFFECTOR Therapeutics Company Details
11.3.2 eFFECTOR Therapeutics Business Overview
11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.3.5 eFFECTOR Therapeutics Recent Developments
11.4 Immunomedics(Gilead Sciences, Inc.)
11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details
11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Developments
11.5 Myovant Biosciences
11.5.1 Myovant Biosciences Company Details
11.5.2 Myovant Biosciences Business Overview
11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.5.5 Myovant Biosciences Recent Developments
11.6 SeleXel
11.6.1 SeleXel Company Details
11.6.2 SeleXel Business Overview
11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.6.5 SeleXel Recent Developments
11.7 Zenith Epigenetics Ltd.
11.7.1 Zenith Epigenetics Ltd. Company Details
11.7.2 Zenith Epigenetics Ltd. Business Overview
11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.7.5 Zenith Epigenetics Ltd. Recent Developments
11.8 VasGene Therapeutics, Inc.
11.8.1 VasGene Therapeutics, Inc. Company Details
11.8.2 VasGene Therapeutics, Inc. Business Overview
11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.8.5 VasGene Therapeutics, Inc. Recent Developments
11.9 Telix Pharmaceuticals
11.9.1 Telix Pharmaceuticals Company Details
11.9.2 Telix Pharmaceuticals Business Overview
11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.9.5 Telix Pharmaceuticals Recent Developments
11.10 Arvinas Inc.
11.10.1 Arvinas Inc. Company Details
11.10.2 Arvinas Inc. Business Overview
11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.10.5 Arvinas Inc. Recent Developments
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.11.5 Amgen Recent Developments
11.12 Genentech
11.12.1 Genentech Company Details
11.12.2 Genentech Business Overview
11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022)
11.12.5 Genentech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Mono
Table 3. Key Players of Combination
Table 4. Key Players of Mono/Combination
Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Region (2017-2022)
Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Region (2023-2028)
Table 11. Metastatic Prostate Cancer Treatment Market Trends
Table 12. Metastatic Prostate Cancer Treatment Market Drivers
Table 13. Metastatic Prostate Cancer Treatment Market Challenges
Table 14. Metastatic Prostate Cancer Treatment Market Restraints
Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Metastatic Prostate Cancer Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Metastatic Prostate Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2021)
Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Metastatic Prostate Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Metastatic Prostate Cancer Treatment Revenue Share by Application (2017-2022)
Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Metastatic Prostate Cancer Treatment Revenue Share by Application (2023-2028)
Table 32. North America Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. AB Science Company Details
Table 63. AB Science Business Overview
Table 64. AB Science Metastatic Prostate Cancer Treatment Product
Table 65. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 66. AB Science Recent Developments
Table 67. BeiGene Company Details
Table 68. BeiGene Business Overview
Table 69. BeiGene Metastatic Prostate Cancer Treatment Product
Table 70. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 71. BeiGene Recent Developments
Table 72. eFFECTOR Therapeutics Company Details
Table 73. eFFECTOR Therapeutics Business Overview
Table 74. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product
Table 75. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 76. eFFECTOR Therapeutics Recent Developments
Table 77. Immunomedics(Gilead Sciences, Inc.) Company Details
Table 78. Immunomedics(Gilead Sciences, Inc.) Business Overview
Table 79. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product
Table 80. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 81. Immunomedics(Gilead Sciences, Inc.) Recent Developments
Table 82. Myovant Biosciences Company Details
Table 83. Myovant Biosciences Business Overview
Table 84. Myovant Biosciences Metastatic Prostate Cancer Treatment Product
Table 85. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 86. Myovant Biosciences Recent Developments
Table 87. SeleXel Company Details
Table 88. SeleXel Business Overview
Table 89. SeleXel Metastatic Prostate Cancer Treatment Product
Table 90. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 91. SeleXel Recent Developments
Table 92. Zenith Epigenetics Ltd. Company Details
Table 93. Zenith Epigenetics Ltd. Business Overview
Table 94. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product
Table 95. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 96. Zenith Epigenetics Ltd. Recent Developments
Table 97. VasGene Therapeutics, Inc. Company Details
Table 98. VasGene Therapeutics, Inc. Business Overview
Table 99. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product
Table 100. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 101. VasGene Therapeutics, Inc. Recent Developments
Table 102. Telix Pharmaceuticals Company Details
Table 103. Telix Pharmaceuticals Business Overview
Table 104. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product
Table 105. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 106. Telix Pharmaceuticals Recent Developments
Table 107. Arvinas Inc. Company Details
Table 108. Arvinas Inc. Business Overview
Table 109. Arvinas Inc. Metastatic Prostate Cancer Treatment Product
Table 110. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 111. Arvinas Inc. Recent Developments
Table 112. Amgen Company Details
Table 113. Amgen Business Overview
Table 114. Amgen Metastatic Prostate Cancer Treatment Product
Table 115. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 116. Amgen Recent Developments
Table 117. Genentech Company Details
Table 118. Genentech Business Overview
Table 119. Genentech Metastatic Prostate Cancer Treatment Product
Table 120. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
Table 121. Genentech Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2021 VS 2028
Figure 2. Mono Features
Figure 3. Combination Features
Figure 4. Mono/Combination Features
Figure 5. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Drug Store Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Metastatic Prostate Cancer Treatment Report Years Considered
Figure 10. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Metastatic Prostate Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Metastatic Prostate Cancer Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2021
Figure 14. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2021
Figure 16. North America Metastatic Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Metastatic Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Metastatic Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Metastatic Prostate Cancer Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Metastatic Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Metastatic Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Metastatic Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Metastatic Prostate Cancer Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Metastatic Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Metastatic Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Metastatic Prostate Cancer Treatment Market Size Share by Region (2017-2028)
Figure 36. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Metastatic Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Metastatic Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Metastatic Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Metastatic Prostate Cancer Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Metastatic Prostate Cancer Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Metastatic Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 56. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 57. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 58. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 59. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 60. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 61. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 62. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 63. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 64. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 65. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 66. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Industry Market Size
